Rocket Pharmaceuticals Inc (RCKT)
16.41
+0.35
(+2.18%)
USD |
NASDAQ |
Oct 04, 16:00
16.41
0.00 (0.00%)
After-Hours: 20:00
Rocket Pharmaceuticals Shareholders Equity (Annual): 492.57M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 492.57M |
| December 31, 2022 | 489.69M |
| December 31, 2021 | 454.72M |
| December 31, 2020 | 503.52M |
| December 31, 2019 | 307.30M |
| December 31, 2018 | 194.04M |
| Date | Value |
|---|---|
| December 31, 2017 | 47.76M |
| December 31, 2016 | 73.17M |
| December 31, 2015 | 108.81M |
| December 31, 2014 | -51.56M |
| December 31, 2013 | -38.90M |
| December 31, 2012 | -30.93M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
307.30M
Minimum
2019
503.52M
Maximum
2020
449.56M
Average
489.69M
Median
2022
Shareholders Equity (Annual) Benchmarks
| Apellis Pharmaceuticals Inc | 194.52M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 39.70M |